TY  - GEN
AU  - Kukreja,R C
TI  - Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase
SN  - 0007-1188
PY  - 2007///0510
KW  - 3',5'-Cyclic-GMP Phosphodiesterases
KW  - antagonists & inhibitors
KW  - Animals
KW  - Antihypertensive Agents
KW  - pharmacology
KW  - Carbolines
KW  - Cardiomyopathies
KW  - chemically induced
KW  - Cardiovascular Agents
KW  - Cyclic Nucleotide Phosphodiesterases, Type 5
KW  - Disease Models, Animal
KW  - Doxorubicin
KW  - Endothelium, Vascular
KW  - drug effects
KW  - Enzyme Inhibitors
KW  - Erectile Dysfunction
KW  - drug therapy
KW  - Heart Failure
KW  - Humans
KW  - Hypertension
KW  - Hypertension, Pulmonary
KW  - Imidazoles
KW  - Male
KW  - Myocardial Infarction
KW  - Myocardial Reperfusion Injury
KW  - NG-Nitroarginine Methyl Ester
KW  - Nitric Oxide
KW  - metabolism
KW  - Phosphodiesterase Inhibitors
KW  - Piperazines
KW  - Purines
KW  - Sildenafil Citrate
KW  - Sulfones
KW  - Tadalafil
KW  - Triazines
KW  - Vardenafil Dihydrochloride
KW  - Vasodilator Agents
KW  - Ventricular Remodeling
N1  - Publication Type: Comment; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1038/sj.bjp.0707132
ER  -